Skip to main content
TMCI logo
TMCI
(NASDAQ)
Treace Medical Concepts, Inc.
$4.05-- (--)
Loading... - Market loading

Treace Medical Concepts (TMCI) Company Profile

Complete business overview, executive team, trading details, and corporate information.

Treace Medical Concepts, Inc.
TMCINasdaq Stock MarketHealthcareMedical Devices

About Treace Medical Concepts

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty System, enables surgeons to correct all three dimensions of the bunion deformity, stabilize the first TMT joint, and allow return to weight-bearing in a walking boot; minimally invasive products for four bunion classes; Nanoplasty 3D Minimally Invasive Bunion Correction System delivers a reproducible 3D correction of the bunion deformity through a cosmetically appealing; and Percuplasty Percutaneous 3D Bunion Correction System that provides 3D correction of the bunion deformity through percutaneous incisions. It also provides Adductoplasty System, a system designed for the correction of metatarsus adductus deformities and osteoarthritis of the midfoot; SpeedMTP Rapid Compression Implant; SpeedPlate Implant Fixation Platform to address the fusion of larger bones of the midfoot and rearfoot; SpeedPlate Micro-Quad implant, an implant designed for stability and fit in small incision surgical approaches; and SpeedAkin Anatomic Compression Implant. In addition, the company offers The IntelliGuide patient specific instrumentation provides patient-specific, 3D-printed cut guides, and a pre-operative plan for a complete picture of the deformity and correction. Further, it provides FastGrafter Autografter Harvesting System; SpeedRelease Guided Release Instrument; TriTome Triple-Edge Release Instrument; RazorTome 7mm Precision Osteotome; LapiTome Hooked Bone Removal Osteotome; GreatRelease Rapid MTP Release Instrument; CornerChisel Release Tool; NanoRasp MIS Bone Contouring Tool; FeatherRasp Rapid Bone Contouring Instrument; and Akinator Single-cut Akin Wedge Osteotomy tool. Additionally, the company offers biologics and wedges, such as Treace Allograft Wedges; and CortiFuse Flowable Cortical Fibers. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.

Company Information

CEOJohn Treace
Founded2014
IPO DateApril 23, 2021
Employees450
CountryUnited States
Fiscal YearJanuary - December

Stock Details

ExchangeNasdaq Stock Market (NASDAQ)
CurrencyUSD - USD
TypeStock
SubtypeCommon Stock

Contact Information

Phone904 373 5940
Address
100 Palmetto Park Place Ponte Vedra, Florida 32081 United States

Corporate Identifiers

CIK0001630627
CUSIP89455T109
ISINUS89455T1097
EIN47-1052611
SIC3841

Leadership Team & Key Executives

John T. Treace
Founder, Chairman and Chief Executive Officer
Mark L. Hair CPA
Chief Financial Officer
Scot M. Elder J.D.
Chief Legal and Compliance Officer and Corporate Secretary
Dr. Sean F. Scanlan Ph.D.
Chief Innovation and Marketing Officer
Terry W. Lubben
Chief Operations and Supply Chain Officer
Zac Potter
Senior Vice President and Chief Accounting Officer
Taylor Erickson
Chief Information and Cybersecurity Officer
Brad Barr
Senior Vice President of Sales
Daniel E. Owens
Chief Human Resources Officer
Shana Zink
Senior Vice President of Clinical Affairs and Reimbursement